|
Pfizer begins study of oral drug for prevention of COVID-19 |
mike kraft |
Group Post |
09/27/21 |
|
Pfizer BioNTechvaccine shots have stronger antibody response than Sinovac-- Hong Kong study |
mike kraft |
Group Post |
06/19/21 |
|
Pfizer bivalent COVID-19 booster vaccine highly effective --Israeli study of over 65's |
mike kraft |
Group Post |
04/14/23 |
|
Pfizer CEO confident that its COVID-19 vaccine protects against more severe Delta variant |
mike kraft |
Group Post |
06/14/21 |
|
Pfizer CEO predicts 'constant waves' of COVID-19 because of complacency and politicization |
mike kraft |
Group Post |
05/25/22 |
|
Pfizer CEO predicts life will come back to normal within a year even with new coronavirus variants |
mike kraft |
Group Post |
09/27/21 |
|
Pfizer CEO says omicron vaccine will be ready in March |
mike kraft |
Group Post |
01/10/22 |
|
Pfizer CEO thinks Covid-19 vaccine will work against Omicron variant, but could offer less protection |
mike kraft |
Group Post |
11/29/21 |
|
Pfizer CEO: Third dose of COVID-19 vaccine 'likely' needed within 1 year |
mike kraft |
Group Post |
04/15/21 |
|
Pfizer CEO: ‘Disappointed’ in presidential debate, vows no political pressure on Covid vaccination shot |
mike kraft |
Group Post |
10/01/20 |
|
Pfizer COVID tracking confirms safety for kids, heart issues extremely rare. |
mike kraft |
Group Post |
05/26/23 |
|
Pfizer COVID-19 vaccine 90% effective at preventing hospitalization, but weakens in preventing milder infections --study |
mike kraft |
Group Post |
10/05/21 |
|
Pfizer COVID-19 vaccine safe, effective on adolescents in trial, companies say |
mike kraft |
Group Post |
03/31/21 |
|
Pfizer director says shots for kids under 5 delayed due to low number of Covid cases in trial |
mike kraft |
Group Post |
02/14/22 |
|
Pfizer ends vaccine trial with 95% success rate, paving way for a shot this year |
mike kraft |
Group Post |
11/18/20 |
|
Pfizer hopes to submit vaccine data for children under 5 by early June |
mike kraft |
Group Post |
05/03/22 |
|
Pfizer isn’t sharing Covid vaccines with researchers for next-gen studies; Donates Paxlovid to poorer countries i |
mike kraft |
Group Post |
09/07/22 |
|
Pfizer launches trial to test Covid pill in children |
mike kraft |
Group Post |
03/10/22 |
|
Pfizer more than doubles price of Covid-19 medication Paxlovid, shortages in poorer countries |
mike kraft |
Group Post |
10/19/23 |
|
Pfizer official expects updated COVID-19 vaccine data for kids under 5 by April |
mike kraft |
Group Post |
01/05/22 |
|
Pfizer plans to submit data on a 4th Covid shot to FDA |
mike kraft |
Group Post |
03/14/22 |
|
Pfizer reports its COVID-19 vaccine trial data shows long-term efficacy in adolescents |
mike kraft |
Group Post |
11/22/21 |
|
Pfizer requests emergency authorization for its oral antiviral COVID-19 treatment |
mike kraft |
Group Post |
11/16/21 |
|
Pfizer says booster in children 5-11 raises antibodies against omicron |
FNUOvviyaa |
Group Post |
04/14/22 |
|
Pfizer says COVID treatment Paxlovid fails to prevent spread of infection of household members |
mike kraft |
Group Post |
04/29/22 |
|
Pfizer says COVID-19 vaccine more than 90% effective in kids |
mike kraft |
Group Post |
10/22/21 |
|
Pfizer says early data signals COVID-19 vaccine is effective |
mike kraft |
Group Post |
11/09/20 |
|
Pfizer says it is ready to launch RSV vaccines for older adults, pregnant women |
mike kraft |
Group Post |
03/09/23 |
|
Pfizer Says It Won’t Seek Vaccine Authorization Before Mid-November |
mike kraft |
Group Post |
10/16/20 |
|
Pfizer says its COVID-19 vaccine is safe, effective in kids ages 5 to 11 |
mike kraft |
Group Post |
09/20/21 |
|
Pfizer says its new antiviral pill cuts risk of severe COVID-19 by 89% |
mike kraft |
Group Post |
11/05/21 |
|
Pfizer says testing shows booster restores full protection against COVID-19 |
mike kraft |
Group Post |
10/21/21 |
|
Pfizer says tests show its vaccine is effective against the South African variant |
mike kraft |
Group Post |
04/01/21 |
|
Pfizer seeks FDA approval of updated COVID vaccine booster retooled for Omcron |
mike kraft |
Group Post |
08/22/22 |
|
Pfizer shots protect kids from severe COVID even in omicron --new data |
mike kraft |
Group Post |
03/01/22 |
|
Pfizer signs agreement to allow broader global access to its experimental Covid-19 antiviral pill |
mike kraft |
Group Post |
11/16/21 |
|
Pfizer speeds up its vaccine delivery after J&J pause |
mike kraft |
Group Post |
04/14/21 |
|
Pfizer starts late-stage trial of mRNA-based flu vaccine |
mike kraft |
Group Post |
09/15/22 |
|
Pfizer study estimates its vaccine helped prevent over 110,000 Covid deaths |
mike kraft |
Group Post |
05/16/22 |
|
Pfizer study shows COVID-19 booster can be given along with pneumonia shot |
mike kraft |
Group Post |
01/12/22 |
|
Pfizer submits data to FDA for use of its Covid vaccine for children ages 5 to 11 |
mike kraft |
Group Post |
09/28/21 |
|
Pfizer to offer low-cost medicines, vaccines to poor nations |
mike kraft |
Group Post |
05/25/22 |
|
Pfizer to seek authorization for 2nd Covid booster for people 65 and older |
mike kraft |
Group Post |
03/15/22 |
|
Pfizer to seek OK for 3rd, booster shot, to extend protection |
mike kraft |
Group Post |
07/08/21 |
|
Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states |
mike kraft |
Group Post |
11/17/20 |
|
Pfizer to study using booster shot aimed at virus variant |
mike kraft |
Group Post |
02/25/21 |
|
Pfizer to supply up to 6 million COVID pill courses for lower income countries |
mike kraft |
Group Post |
09/22/22 |
|
Pfizer to test COVID-19 vaccine for children under 12 |
mike kraft |
Group Post |
06/08/21 |
|
Pfizer vaccine efficacy reported to decline in Israel as delta variant spreads |
mike kraft |
Group Post |
07/05/21 |
|
Pfizer vaccine highly effective in real-world study, Israeli researchers say |
mike kraft |
Group Post |
02/25/21 |
Recent Comments